Randomized trial evaluates long-term safety and efficacy of once-nightly sodium oxybate in narcolepsy, indicating potential benefits for untreated patients.
To evaluate safety/efficacy data of once-nightly sodium oxybate (ON-SXB) in the long-term, open-label RESTORE (NCT04451668) study for participants who were not taking an oxybate at study entry.
No takes yet. Share an insight, caveat, or question.
Corser et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: